New biodegradable drug-eluting stents for urethral strictures in a rabbit model

Abstract

In this study, the feasibility and the effect of a new biodegradable drug-eluting urethral stents for the treatment of urethral stricture in a rabbit model were evaluated, and the biocompatibility properties of the new biodegradable drug-eluting urethral stents in the rabbit urethral assessed. A total of 34 male New Zealand White rabbits with urethral strictures were used, and equally divided into two groups: with drug stents and drug-free stents. The urethral strictures were made by using a self-control explosion device as the control. Stents were surgically implanted into the stenotic urethras of rabbits under direct vision. Reparative effects, including biocompatibility assessment, were evaluated by urethroscopy, retrograde urethrography, and histology at different intervals at weeks 4, 8, and 12. Although retrograde urethrography and urodynamic results at 12 weeks showed no comparable differences among the three groups, urethroscopic and histological follow-up indicated that the drug stents had minimized the stent-related inflammatory responses, urothelial hyperplasia, and scar formation compared with the drug-free stents. The new biodegradable paclitaxel-eluting stents were more biocompatible and effective for treating urethral strictures in the rabbit model than the drug-free stents.

Keywords

biodegradable drug-eluting stents paclitaxel-eluting stents urethral strictures

Get full access to this article

View all access options for this article.

References

Zehri AA , Ather MH and Afshan Q. Predictors of recurrence of urethral stricture disease following optical urethrotomy . Int J Surg 2009; 7: 361-364.

Liatsikos E. , Kallidonis P. , Stolzenburg JU and Karnabatidis D. Ureteral stents: past, present and future. Expert Rev Med Devices 2009; 6: 313-324.

Fu WJ , Zhang BH , Gao JP , Hong BF , Zhang L. , Yang Y. , et al. Biodegradable urethral stent in the treatment of post-traumatic urethral strictures in a war wound rabbit urethral model. Biomed Mater 2007; 2: 263-268.

Palminteri E.

Stents and urethral strictures: a lesson learned?

Eur Urol 2008; 54: 498-500

Milroy EJ , Chapple CR , Cooper JE , Eldin A. , Wallsten H. , Seddon AM , et al. A new treatment for urethral strictures. Lancet 1988; 1: 1424-1427.

Kirby RS , Heard SR , Miller P. , Eardley I. , Holmes S. , Vale J. , et al. Use of the asi titanium stent in the management of bladder outflow obstruction due to benign prostatic hyperplasia. J Urol 1992; 148: 1195-1197.

De Vocht TF , van Venrooij GE and Boon TA Self-expanding stent insertion for urethral strictures: a 10-year follow-up . BJU Int 2003; 91: 627-630.

Papatsoris AG , El-Husseiny T. , Sawada Y. , Takahashi T. , Nagaoka A. , Maan Z. , et al. Treating bladder-outflow obstruction with thermoexpandable prostate metal stents. Expert Rev Med Devices 2009; 6: 357-363.

Multanen M. , Tammela TL , Laurila M. , Seppälä J. , Välimaa T. , Törmälä P. , et al. Biocompatibility, encrustation and biodegradation of ofloxacine and silver nitrate coated poly-l-lactic acid stents in rabbit urethra. Urol Res 2002; 30: 227-232.

10.

Choi EK , Song HY , Shin JH , Lim JO , Park H. and Kim CS Management of recurrent urethral strictures with covered retrievable expandable nitinol stents: long-term results. AJR Am J Roentgenol 2007; 189: 1517-1522.

11.

De Giglio E. , Cafagna D. , Ricci MA , Sabbatini L. , Cometa S. , Ferretti C. , et al. Biocompatibility of poly(acrylic acid) thin coatings electro-synthesized onto TiALV-based stent implants. J Bioact Compat Polym 2010; 4: 374-391.

12.

Isotalo T. , Talja M. , Välimaa T. , Törmälä P. and Tammela TL A bioabsorbable self-expandable, self-reinforced poly(L-lactic acid) urethral stent for recurrent urethral strictures: long-term results. J Endourol 2002; 16: 759-762.

13.

Isotalo T. , Nuutinen JP , Vaajanen A. , Martikainen PM , Laurila M. , Törmälä P. , et al. Biocompatibility properties of a new braided biodegradable urethral stent: a comparison with a biodegradable spiral and a braided metallic stent in the rabbit urethra. BJU Int 2006; 97: 856-859.

14.

Isotalo T. , Nuutinen JP , Vaajanen A. , Martikainen PM , Laurila M. , Törmälä P. , et al. Biocompatibility and implantation properties of 2 differently braided, biodegradable, self-reinforced poly(lactic acid) urethral stents: an experimental study in the rabbit. J Urol 2005; 174: 2401-2402.

15.

Slavin L. , Chhabra A. and Tobis JM Drug-eluting stents: preventing restenosis. Cardiol Rev 2007; 15: 1-12.

16.

Wei XH , Niu YP , Xu YY , Du Y. , Hu F. and Yuan H. Salicylic acid-grafted chitosan oligosaccharide nanoparticle for paclitaxel delivery. J Bioact Compat Polym 2010; 3: 319-335.

17.

Liatsikos EN , Karnabatidis D. , Kagadis GC , Rokkas K. and Constantinides C. Application of paclitaxel-eluting metal mesh stents within the pig ureter: an experimental study. Eur Urol 2007; 51: 217-223.

18.

Shin JH , Song HY , Choi CG , Yuk SH , Kim JS , Kim YM , et al. Tissue hyperplasia: influence of a paclitaxel-eluting covered stent-preliminary study in a canine urethral model. Radiology 2005; 234: 438-444.

19.

Kotsar A. , Isotalo T. , Uurto I. , Mikkonen J. , Martikainen P. , Talja M. , et al. Urethral in situ biocompatibility of new drug-eluting biodegradable stents: an experimental study in the rabbit. BJU Int 2009; 103: 1132-1135.

20.

Kotsar A. , Nieminen R. , Isotalo T. , Mikkonen J. , Uurto I. , Kellomäki M. , et al. Biocompatibility of new drug-eluting biodegradable urethral stent materials. Urology 2010; 75: 229-234.